Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
During a presentation at American Society of Retina Specialists 2021 annual meeting in San Antonio, Sunir Garg, MD, presented data showing that universal masking does not seem to increase the risk of developing endophthalmitis, and it may cause a reduction in culture positive endophthalmitis.
During a presentation at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Texas, Yoshihiro Yonekawa, MD, warned of the potential risk of endophthalmitis with the use of implantable MIGS devices.
Speaking at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Rishi P. Singh, MD, provided results of the VISTA and VIVID studies, and he pointed out that the findings could help physicians set expectations of DME therapy.
During a presentation at the American Society of Retina Specialists 2021 annual meeting in San Antonio, W. Lloyd Clark, MD, presented results of the PANORAMA Study. The focus of the study, Clark said, was to identify the factors that increase the risk of complications in patients with nonproliferative diabetic retinopathy to provide information for making decisions on treatment choices.
Researchers set out to identify clinical and anatomic factor-associated vision loss in eyes with treatment-naïve DME and good initial VA.
In PIONEER study, investigators outline successes.
A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.
Investigators find that wearable aid offers improved mobility.
Anterior uveitis therapy offers anti-inflammatory effect after dosing is stopped.
During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment.
In a presentation at the EURETINA 2021 Virtual Conference, Tunde Peto, MD, PhD, pointed out that while complications associated with diabetes develop over a long period, ophthalmologists today have an excellent understanding of diabetes-related eye changes.
During a presentation at the EURETINA 2021 Virtual Congress, Daniel Jones, PhD, discussed GA and emphasized the need for additional study to gain a better understanding of the burden experienced by patients.
In a presentation at the EURETINA 2021 Virtual Congress, Cristina Cristian, MD, noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.
During a presentation at the EURETINA 2021 Virtual Congress, Anat Loewenstein, MD, MHA, discussed how artificial intelligence can optimize optical coherence tomography.
During a presentation at the EURETINA 2021 Virtual Congress, José-Alain Sahel, MD, explains that optogenetics involves the use of artificial photoreceptors from specific retinal cells to restore vision by transferring a gene that encodes for a light-sensitive protein that causes neuronal cells to respond to light stimulation.
This conference titled, “The Top Ten Things I Wish I Knew Sooner,” is the brainchild of Lisa M. Nijm, MD, JD, who has had the foresight to help young ophthalmologists negotiate the choppy waters of a new practice.
Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Chekitaan Singh, MD, discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.
Speaking during the EURETINA 2021 Virtual Congress, Marta Belmonte-Grau, MD, discussed the potential risk for posterior capsular rupture during cataract surgery.
Investigators find imaging method may be useful to monitor disease progression.
Development of new animal model enhances study of genetic mutations.
Study examines immunomodulatory as a potential long-term treatment option.
Scanning laser ophthalmoscopy offers improved view of posterior segment.
Approval may inspire increased vaccination effort.
Findings from the Archway trial showed that the PDS effect is long-lasting, consistent, and comparable to those seen with monthly injections.
Visual benefit is not seen during first 2 years of Protocol W study.
Dexamethasone implant, aflibercept offer a safe treatment option for diabetic macular edema.
Results may represent a retinal degenerative change.
The EURETINA 2021 Virtual Meeting is scheduled for September 9 to 12, 2021, and retina specialists eagerly await the showcase of cutting-edge scientific developments.
Investigators have found that 78% of neovascular AMD cases have been detected using the PHP home monitoring system.
A team of investigators found that the retina may offer signs of COVID-19 infection before symptoms present.
